Illegal aliens.
Not subject to the jurisdiction thereof, not citizens.
The man is 100 percent correct.
Rumpswab wants to deport American citizens? to WHERE exactly? How about deport their ILLEGAL parents and of course the ILLEGAL parents will take the kids with them, problem solved. OR how about you slam the border shut? This rumbswab is annoying, he will NOT be the nominee thank God and I hope Trump does NOT consider him for any important position.
Is Vivek Ramaswamy the Biz Whiz He Claims to Be? Burned Investors Might Disagree
Vivek Ramaswamy, the fast-talking, Ivy League-educated, telegenic political phenom thrills Republican voters, infuriates his presidential primary opponents and styles himself as an entrepreneurial “scientist” with a glittering business background and hundreds of millions of dollars to dump into his out-of-nowhere campaign for the White House.
But a review of Ramaswamy’s career – marked by the hyping of a failed Alzheimer’s drug, giant payouts when other investors got burned, lawsuits alleging pressure to break securities laws and more – reveals a businessperson whose true liquid net worth is unknown and whose track record as a successful entrepreneur shows limited value creation for anyone other than himself.
Alzheimer’s Drug Failure
By far the most prominent effort – and biggest failure – in Ramaswamy’s business career came when his biotech company, Axovant Sciences, acquired rights to a potential drug to fight Alzheimer’s disease.
Axovant was a brand-new company. And beyond an undergraduate degree in biology, Ramaswamy had no experience in pharmaceutical research or any further scientific training. The drug was called Intepirdine, and the $34.6 billion pharmaceutical company GlaxoSmithKline, having given up on the drug’s prospects, sold it to Axovant for $5 million and other considerations.
Ramaswamy rang the opening bell at the New York Stock Exchange in June of 2015 – alongside his new bride – when Axovant became the biggest-ever biotech IPO at the time, raising $315 million and eventually winning a valuation of $3 billion.